TNFRSF12A and glioma: Clinical correlation analysis of the CGGA data demonstrated that the expression level for TNFRSF12A was significantly correlated with PRS type, histology, grade, age, chemotherapy, IDH mutations, and 1p19q co-deletion in glioma samples.